Product Name

  • Name

    Asparkam

  • EINECS
  • CAS No. 14842-81-0
  • Density g/cm3
  • Solubility
  • Melting Point
  • Formula C8H10MgN2O8•C4H7NO4•2H•K
  • Boiling Point 264.1°Cat760mmHg
  • Molecular Weight 460.75
  • Flash Point 113.5°C
  • Transport Information
  • Appearance
  • Safety Moderately toxic by intravenous route. When heated to decomposition it emits toxic fumes of NOx and K2O.
  • Risk Codes
  • Molecular Structure Molecular Structure of 14842-81-0 (Asparkam)
  • Hazard Symbols
  • Synonyms L-Aspartic acid,compounds,monopotassium salt,mixt. with dihydrogen (T-4)-bis[L-aspartato(2-)-kN,kO1]magnesate- (2-);Spartase;Aspara;Trophicard;L-Asparkam;MAGNESIUM POTASSIUM-l-ASPARTATE;ASPARTAT;
  • PSA 310.35000
  • LogP -5.28420

Asparkam Chemical Properties

Molecular Structure of Asparkam (CAS NO.14842-81-0):

IUPAC Name:  magnesium; potassium; (2S)-2-amino-4-hydroxy-4-oxobutanoate; 2-amino-4-hydroxy-4-oxobutanoate
Empirical Formula: C12H18KMgN3O12 
Molecular Weight: 459.6875 
Flash Point: 113.5 °C 
Enthalpy of Vaporization: 55.26 kJ/mol 
Boiling Point: 264.1 °C at 760 mmHg 
Vapour Pressure: 0.00289 mmHg at 25°C 
Classification Code : Drug / Therapeutic Agent ; Nutrient
Synonyms of Asparkam (CAS NO.14842-81-0):  L-Aspartic acid, monopotassium salt, mixt. with dihydrogen (T-4)-bis(L-aspartato(2-)-N,O(sup 1)magnesate(2-) ; L-Aspartic acid, monopotassium salt, mixt. with dihydrogen (T-4)-bis(L-aspartato(2-)-kappaN,kappaO1)magnesate(2-) ; L-Asparkam ; Aspartic acid, L-, magnesium salt (2:1) tetrahydrate, mixture with potassium hydrogen L-aspartate hemihydrate ; Asparkam ; Aspara

Asparkam Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intravenous 817mg/kg (817mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
mouse LD50 oral > 10gm/kg (10000mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
mouse LD50 subcutaneous 4226mg/kg (4226mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
rat LD50 intraperitoneal > 2gm/kg (2000mg/kg)   Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 9, Pg. 759, 1967.
rat LD50 intravenous 619mg/kg (619mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
rat LD50 oral > 10gm/kg (10000mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.
rat LD50 subcutaneous 6902mg/kg (6902mg/kg)   Drugs in Japan Vol. 6, Pg. 11, 1982.

Asparkam Consensus Reports

 Magnesium potassium aspartate (CAS NO.14842-81-0) was reported in NIIRDN Drugs in Japan (Ethical Drugs).

Asparkam Safety Profile

Moderately toxic by intravenous route. When heated to decomposition it emits toxic fumes of NOx and K2O.

Related Products

Hot Products

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View